(HealthDay)—For men with nonmetastatic, castration-resistant prostate cancer, the risk for death is significantly lower for those receiving darolutamide versus placebo, according to a study published in the Sept. 10 issue ...
Sep 15, 2020
0
3
(HealthDay)—A metabolomics screening tool may detect more than 50 percent of individuals with autism spectrum disorder (ASD), according to a study published online June 18 in Autism Research.
Jul 27, 2020
0
5
(HealthDay)—For patients with transfusion-dependent β-thalassemia, significantly more have a reduction in transfusion burden with receipt of luspatercept versus placebo, according to a study published in the March 26 issue ...
Mar 26, 2020
0
0
Studies of indoor tanning that are financially linked to the industry are significantly more likely to downplay the risks and highlight perceived benefits of indoor tanning than studies without such ties, according to researchers ...
Feb 4, 2020
0
6
(HealthDay)—Suvorexant improves total sleep time (TST) in patients with probable Alzheimer disease (AD) dementia and insomnia, according to a study published online Jan. 15 in Alzheimer's & Dementia.
Jan 29, 2020
0
2
(HealthDay)—Standardized screening for autism spectrum disorder (ASD) is recommended at ages 18 and 24 months in primary care, according to a clinical report published online Dec. 16 in Pediatrics.
Dec 23, 2019
0
3
(HealthDay)—Childhood vaccination with the bacille Calmette-Guérin (BCG) vaccine is associated with a reduced risk for lung cancer, according to a study published online Sept. 25 in JAMA Network Open.
Nov 18, 2019
0
13
(HealthDay)—Allergy immunotherapy (AIT) is associated with a decreased risk for asthma progression, particularly in younger patients, according to a study published online Aug. 13 in Allergy.
Sep 12, 2019
0
1
(HealthDay)—A staging system of β-amyloid (Aβ) accumulation may be useful for monitoring patients throughout the course of Alzheimer disease (AD), according to a study published online July 17 in JAMA Neurology to coincide ...
Jul 18, 2019
0
3
(HealthDay)—For patients with osteoarthritis (OA) of the knee or hip, tanezumab is associated with significant improvements in pain and physical function versus placebo, according to a study published in the July 2 issue ...
Jul 3, 2019
0
1
